Hostname: page-component-89b8bd64d-n8gtw Total loading time: 0 Render date: 2026-05-06T01:14:12.441Z Has data issue: false hasContentIssue false

Associations between serum carotenoid levels and the risk of non-Hodgkin lymphoma: a case–control study

Published online by Cambridge University Press:  30 April 2020

Shan Li
Affiliation:
Department of Lymphoma, Cancer Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, People’s Republic of China
Xianglu Zhu
Affiliation:
Department of Breast Radiotherapy, Cancer Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, People’s Republic of China
Lin Zhu
Affiliation:
Department of Lymphoma, Cancer Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, People’s Republic of China
Xin Hu
Affiliation:
Department of Lymphoma, Cancer Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, People’s Republic of China
Shujuan Wen*
Affiliation:
Department of Lymphoma, Cancer Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, People’s Republic of China
*
*Corresponding author: Dr Shujuan Wen, fax +86 991 7968111, email wudaq245@126.com
Rights & Permissions [Opens in a new window]

Abstract

Limited studies have investigated the effects of serum carotenoids on the risk of non-Hodgkin lymphoma (NHL), and the findings have been inconclusive. This study aims to assess the association between serum total or specific carotenoid levels and NHL risk. This 1:1 matched, hospital-based case–control study enrolled 512 newly diagnosed (within 1 month) NHL patients and 512 healthy controls who were matched by age (±5 years) and sex in Urumqi, China. Serum carotenoid levels were measured by HPLC. Conditional logistic regression showed that higher serum total carotenoid levels and their subtypes (e.g. α-carotene, β-carotene, β-cryptoxanthin and lycopene) were dose-dependently associated with decreased NHL risk. The multivariable-adjusted OR and their 95 % CI for NHL risk for quartile 4 (v. quartile 1) were 0·31 (95 % CI 0·22, 0·48; Pfor trend < 0·001) for total carotenoids, 0·52 (95 % CI 0·33, 0·79; Pfor trend: 0·003) for α-carotene, 0·63 (95 % CI 0·42, 0·94; Pfor trend: 0·031) for β-carotene, 0·73 (95 % CI 0·49, 1·05; Pfor trend: 0·034) for β-cryptoxanthin and 0·51 (95 % CI 0·34, 0·75; Pfor trend: 0·001) for lycopene. A null association was observed between serum lutein + zeaxanthin and NHL risk (OR 0·89, 95 % CI 0·57, 1·38; Pfor trend: 0·556). Significant interactions were observed after stratifying according to smoking status, and inverse associations were more evident among current smokers than past or never smokers for total carotenoids, α-carotene and lycopene (Pfor heterogeneity: 0·047, 0·042 and 0·046). This study indicates that higher serum carotenoid levels might be inversely associated with NHL risk, especially among current smokers.

Information

Type
Full Papers
Copyright
© The Authors 2020. Published by Cambridge University Press on behalf of the Nutrition Society
Figure 0

Table 1. Basic characteristics of non-Hodgkin lymphoma cases and matched controls*(Mean values and standard deviations; numbers and percentages)

Figure 1

Table 2. Serum carotenoid levels among cases and control subjects (μmol/dl)*(Mean values and standard deviations; median values and 25th, 75th percentiles)

Figure 2

Table 3. Association between serum carotenoid levels and non-Hodgkin lymphoma risk(Odds ratios and 95 % confidence intervals)

Figure 3

Table 4. Conditional logistic regression analyses of lymphoma according to quartiles of serum carotenoids by subtypes*(Odds ratios and 95 % confidence intervals)

Figure 4

Table 5. Unconditional logistic regression analyses of lymphoma according to quartiles of serum carotenoids by smoking status*(Odds ratios and 95 % confidence intervals)